Mergetpa

Mergetpa is a carboxypeptidase inhibitor used to block the conversion of kinins and B2 receptor antagonists to metabolites lacking the C-terminal arginine[1].

Product Specifications

CAS Number

[77102-28-4]

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Carboxypeptidase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/mergetpa.html

Purity

95.20

Solubility

H2O : 15 mg/mL (ultrasonic)

Smiles

O=C(C(CSCCNC(N)=N)CS)O

Molecular Formula

C7H15N3O2S2

Molecular Weight

237.34

Precautions

H302, H315, H319, H335

References & Citations

[1]D Regoli, et al. Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels. Eur J Pharmacol. 1986 Aug 15;127 (3) :219-24.